In addition, upregulated NF-κB signaling alone or in combination with other signaling pathways elevates other processes associated with BC aggressiveness and therapy resistance, such as the EMT, neovascularization, and increase in cancer cell “stemness” [7, 66]. Here, NFKB1 is linked to breast cancer.